BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33078140)

  • 21. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England.
    Fulop NJ; Walton H; Crellin N; Georghiou T; Herlitz L; Litchfield I; Massou E; Sherlaw-Johnson C; Sidhu M; Tomini SM; Vindrola-Padros C; Ellins J; Morris S; Ng PL
    Health Soc Care Deliv Res; 2023 Jul; 11(13):1-151. PubMed ID: 37800997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covid-19: Rates fell rapidly on Isle of Wight after test and trace launch, early data show.
    Iacobucci G
    BMJ; 2020 Jul; 370():m2861. PubMed ID: 32675110
    [No Abstract]   [Full Text] [Related]  

  • 24. Measuring the scientific effectiveness of contact tracing: Evidence from a natural experiment.
    Fetzer T; Graeber T
    Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cohort Profile: The Isle Of Wight Whole Population Birth Cohort (IOWBC).
    Arshad SH; Holloway JW; Karmaus W; Zhang H; Ewart S; Mansfield L; Matthews S; Hodgekiss C; Roberts G; Kurukulaaratchy R
    Int J Epidemiol; 2018 Aug; 47(4):1043-1044i. PubMed ID: 29547889
    [No Abstract]   [Full Text] [Related]  

  • 26. Covid-19 vaccine roll-out in England: A qualitative evaluation.
    Mounier-Jack S; Paterson P; Bell S; Letley L; Kasstan B; Chantler T
    PLoS One; 2023; 18(6):e0286529. PubMed ID: 37267295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to COVID-19 in South Korea and implications for lifting stringent interventions.
    Dighe A; Cattarino L; Cuomo-Dannenburg G; Skarp J; Imai N; Bhatia S; Gaythorpe KAM; Ainslie KEC; Baguelin M; Bhatt S; Boonyasiri A; Brazeau NF; Cooper LV; Coupland H; Cucunuba Z; Dorigatti I; Eales OD; van Elsland SL; FitzJohn RG; Green WD; Haw DJ; Hinsley W; Knock E; Laydon DJ; Mellan T; Mishra S; Nedjati-Gilani G; Nouvellet P; Pons-Salort M; Thompson HA; Unwin HJT; Verity R; Vollmer MAC; Walters CE; Watson OJ; Whittaker C; Whittles LK; Ghani AC; Donnelly CA; Ferguson NM; Riley S
    BMC Med; 2020 Oct; 18(1):321. PubMed ID: 33032601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a COVID-19 surveillance programme for healthcare workers in a teaching hospital in an upper-middle-income country.
    Wan KS; Tok PSK; Yoga Ratnam KK; Aziz N; Isahak M; Ahmad Zaki R; Nik Farid ND; Hairi NN; Rampal S; Ng CW; Samsudin MF; Venugopal V; Asyraf M; Damanhuri NH; Doraimuthu S; Arumugam CT; Marthammuthu T; Nawawi FA; Baharudin F; Chong DWQ; Jayaraj VJ; Magarita V; Ponnampalavanar S; Hasnan N; Kamarulzaman A; Said MA
    PLoS One; 2021; 16(4):e0249394. PubMed ID: 33852588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological impacts of the NHS COVID-19 app in England and Wales throughout its first year.
    Kendall M; Tsallis D; Wymant C; Di Francia A; Balogun Y; Didelot X; Ferretti L; Fraser C
    Nat Commun; 2023 Feb; 14(1):858. PubMed ID: 36813770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.
    Kucharski AJ; Klepac P; Conlan AJK; Kissler SM; Tang ML; Fry H; Gog JR; Edmunds WJ;
    Lancet Infect Dis; 2020 Oct; 20(10):1151-1160. PubMed ID: 32559451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NHS Test and Trace's aims "overstated or not achieved".
    Burki T
    Lancet Infect Dis; 2021 Dec; 21(12):1637-1638. PubMed ID: 34838230
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment.
    Jarvis CI; Gimma A; van Zandvoort K; Wong KLM; ; Edmunds WJ
    BMC Med; 2021 Feb; 19(1):52. PubMed ID: 33602244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in UK NHS hospitals.
    Blackstone J; Stirrup O; Mapp F; Panca M; Copas A; Flowers P; Hockey L; Price J; Partridge D; Peters C; de Silva T; Nebbia G; Snell LB; McComish R; ; Breuer J
    BMJ Open; 2022 Apr; 12(4):e052514. PubMed ID: 35440446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trade-offs between location and waiting times in the provision of health care: the case of elective surgery on the Isle of Wight.
    Ryan M; McIntosh E; Dean T; Old P
    J Public Health Med; 2000 Jun; 22(2):202-10. PubMed ID: 10912560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling framework.
    Booton RD; MacGregor L; Vass L; Looker KJ; Hyams C; Bright PD; Harding I; Lazarus R; Hamilton F; Lawson D; Danon L; Pratt A; Wood R; Brooks-Pollock E; Turner KME
    BMJ Open; 2021 Jan; 11(1):e041536. PubMed ID: 33414147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SARS-CoV-2 pandemic: the race to trace: contact tracing scale-up in San Francisco-early lessons learned.
    Reid M; Enanoria W; Stoltey J; Philip S; Fuchs J; Lockwood A; Krueger E; White K; Celentano J; Rutherford G; Scheer S; Nguyen T; Sachdev D
    J Public Health Policy; 2021 Jun; 42(2):211-221. PubMed ID: 34088978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing.
    Anderson LF; Tamne S; Brown T; Watson JP; Mullarkey C; Zenner D; Abubakar I
    Lancet Infect Dis; 2014 May; 14(5):406-15. PubMed ID: 24602842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.